IBDEI39M ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,52115,1,3,0)
 ;;=3^Progressive Supranuclear Ophthalmoplegia
 ;;^UTILITY(U,$J,358.3,52115,1,4,0)
 ;;=4^G23.1
 ;;^UTILITY(U,$J,358.3,52115,2)
 ;;=^5003780
 ;;^UTILITY(U,$J,358.3,52116,0)
 ;;=Z79.2^^193^2518^1
 ;;^UTILITY(U,$J,358.3,52116,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52116,1,3,0)
 ;;=3^Antibiotics
 ;;^UTILITY(U,$J,358.3,52116,1,4,0)
 ;;=4^Z79.2
 ;;^UTILITY(U,$J,358.3,52116,2)
 ;;=^321546
 ;;^UTILITY(U,$J,358.3,52117,0)
 ;;=Z79.01^^193^2518^2
 ;;^UTILITY(U,$J,358.3,52117,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52117,1,3,0)
 ;;=3^Anticoagulants
 ;;^UTILITY(U,$J,358.3,52117,1,4,0)
 ;;=4^Z79.01
 ;;^UTILITY(U,$J,358.3,52117,2)
 ;;=^5063330
 ;;^UTILITY(U,$J,358.3,52118,0)
 ;;=Z79.02^^193^2518^3
 ;;^UTILITY(U,$J,358.3,52118,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52118,1,3,0)
 ;;=3^Antiplatelets/Antithrombotics
 ;;^UTILITY(U,$J,358.3,52118,1,4,0)
 ;;=4^Z79.02
 ;;^UTILITY(U,$J,358.3,52118,2)
 ;;=^5063331
 ;;^UTILITY(U,$J,358.3,52119,0)
 ;;=Z79.82^^193^2518^4
 ;;^UTILITY(U,$J,358.3,52119,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52119,1,3,0)
 ;;=3^Aspirin
 ;;^UTILITY(U,$J,358.3,52119,1,4,0)
 ;;=4^Z79.82
 ;;^UTILITY(U,$J,358.3,52119,2)
 ;;=^5063340
 ;;^UTILITY(U,$J,358.3,52120,0)
 ;;=Z79.4^^193^2518^6
 ;;^UTILITY(U,$J,358.3,52120,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52120,1,3,0)
 ;;=3^Insulin
 ;;^UTILITY(U,$J,358.3,52120,1,4,0)
 ;;=4^Z79.4
 ;;^UTILITY(U,$J,358.3,52120,2)
 ;;=^5063334
 ;;^UTILITY(U,$J,358.3,52121,0)
 ;;=Z79.1^^193^2518^9
 ;;^UTILITY(U,$J,358.3,52121,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52121,1,3,0)
 ;;=3^NSAID
 ;;^UTILITY(U,$J,358.3,52121,1,4,0)
 ;;=4^Z79.1
 ;;^UTILITY(U,$J,358.3,52121,2)
 ;;=^5063332
 ;;^UTILITY(U,$J,358.3,52122,0)
 ;;=Z79.891^^193^2518^8
 ;;^UTILITY(U,$J,358.3,52122,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52122,1,3,0)
 ;;=3^Long Term Opiate/Opioid Analgesic Use
 ;;^UTILITY(U,$J,358.3,52122,1,4,0)
 ;;=4^Z79.891
 ;;^UTILITY(U,$J,358.3,52122,2)
 ;;=^5063342
 ;;^UTILITY(U,$J,358.3,52123,0)
 ;;=Z79.51^^193^2518^5
 ;;^UTILITY(U,$J,358.3,52123,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52123,1,3,0)
 ;;=3^Inhaled Steroids
 ;;^UTILITY(U,$J,358.3,52123,1,4,0)
 ;;=4^Z79.51
 ;;^UTILITY(U,$J,358.3,52123,2)
 ;;=^5063335
 ;;^UTILITY(U,$J,358.3,52124,0)
 ;;=Z79.52^^193^2518^11
 ;;^UTILITY(U,$J,358.3,52124,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52124,1,3,0)
 ;;=3^Steroids-Systemic
 ;;^UTILITY(U,$J,358.3,52124,1,4,0)
 ;;=4^Z79.52
 ;;^UTILITY(U,$J,358.3,52124,2)
 ;;=^5063336
 ;;^UTILITY(U,$J,358.3,52125,0)
 ;;=Z79.899^^193^2518^7
 ;;^UTILITY(U,$J,358.3,52125,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52125,1,3,0)
 ;;=3^Long Term Current Drug Therapy NEC
 ;;^UTILITY(U,$J,358.3,52125,1,4,0)
 ;;=4^Z79.899
 ;;^UTILITY(U,$J,358.3,52125,2)
 ;;=^5063343
 ;;^UTILITY(U,$J,358.3,52126,0)
 ;;=Z79.84^^193^2518^10
 ;;^UTILITY(U,$J,358.3,52126,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52126,1,3,0)
 ;;=3^Oral Hypoglycemic Drugs
 ;;^UTILITY(U,$J,358.3,52126,1,4,0)
 ;;=4^Z79.84
 ;;^UTILITY(U,$J,358.3,52126,2)
 ;;=^5140432
 ;;^UTILITY(U,$J,358.3,52127,0)
 ;;=Z90.13^^193^2519^5
 ;;^UTILITY(U,$J,358.3,52127,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,52127,1,3,0)
 ;;=3^Acquired Absence of Breasts & Nipples,Bilateral
 ;;^UTILITY(U,$J,358.3,52127,1,4,0)
 ;;=4^Z90.13
 ;;^UTILITY(U,$J,358.3,52127,2)
 ;;=^5063584
 ;;^UTILITY(U,$J,358.3,52128,0)
 ;;=Z90.710^^193^2519^6
